期刊文献+

240例肝硬化患者血清病毒标志物分析

Analysis of virus indication in the serum of 240 patients with livercirrhosis
下载PDF
导出
摘要 目的 探讨肝硬化患者血清病毒的感染模式及临床意义。方法 采用ELISA法检测甲—庚型肝炎病毒抗原或抗体 ,PCR法检测HBVDNA ,HCVRNA。结果  2 40例肝硬化血清病毒的感染率依次为 :HBV >HCV >HDV >HGV >HEV >HAV。HBVDNA阳性率为 61 2 5 % ,HCVRNA阳性率为 15 2 2 %。结论 肝硬化以HBV的感染的“小三阳”为主要模式 ,以HBV ,HCV ,和 /或HDV ,HGV ,HEV双重及多重感染为多见 ,病毒核酸 (HBVD NA ,HCVRNA) Objectiv: To investigate the infection mode of virus in the serum of patients with livercirrhosis. Methods: ELISA method was used to examine antigens or antibodies of hepatitis virus and PCR was used to detect HBVDNA and HCVRNA in serum. Results: In 240 patients with livercirrhosis, HBVDNA was 61.25%, HCVRNA 15.22%, and the percentages of HBV, HCV, HDV, HGV, HEV and HAV decreased in order. Conclusion: Most of the cases of livercirrhosis are correlated with HBV infection and a lot of them with HBV/HCV or HBV/HCV/HDV/HGV/HEV infection. Virus nucleic acid such as HBVDNA, HCVRNA is the direct evidence that the infectiousness of livercirrhosis can be estimated.
机构地区 泰山医学院
出处 《泰山医学院学报》 CAS 2002年第4期357-358,共2页 Journal of Taishan Medical College
关键词 肝硬化 血清 病毒标志物 聚合酶链反应 livercirrhosis hepatitis virus virus indication PCR
  • 相关文献

参考文献4

二级参考文献23

  • 1郝飞,顾长海,王阁李梦东,陈国致.重型肝炎患者丙型肝炎病毒抗体的存在状态及其意义[J].解放军医学杂志,1995,20(3):182-185. 被引量:6
  • 2[1]Walsh K, Alexander GJM. Update on chronic viral hepatitis Postgrad Med J, 2001,77:498~505.
  • 3[2]McQuillan GM,Coleman PJ,Kruszon-Moran D,et al. Prevalence of hepatitis B virus infection in the United States:the Nationsl Health and Nutrition Examination Survey. Am J Public Health, 1999, 89:14~18.
  • 4[3]Colin JF,Cazals-Hatem D,Loriot MA,et al.Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.Hepatology,1999,29:1306~1310.
  • 5[4]Ruiz-Moreno M, Otero M, Millan A,et al. Clinical and histological outcome after hepatitis B eody seroconversion in chiildren with chronic hepatitis antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology, 1999,29:572~575.
  • 6[5]Fursusyo N, Hayshi J,Sawayama Y,et al. Hepatitis B surface antigen disapperance and hepatitis B surface antigen subtype: a prospective, long-term follow-up study of Japanese resident of Okinawa, Japan with chronic hepatitis b virus infection. Am J Trop Med Hyg, 1999,60:616~622.
  • 7[6]Momosaka Y, Yamada S, Harada Y. Change of the host immune response during the early phase of interferon therapy correlates with its long-term efficacy for chronic hepatitis C.Hepatol Res, 2001,19:131~143.
  • 8[7]Lin S-M,Sheen I-S,Chien R-N, et al. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology, 1999,29:971~975.
  • 9[8]Boni C, Penna A, Ogg GS, et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy, Hepatology, 2001,33:963~971.
  • 10[9]EASL International Consensus Conference on Hepatitis C. J Hepatol, 1999,30:956~961.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部